ALGN
Price
$155.51
Change
+$4.14 (+2.74%)
Updated
Oct 22 closing price
Capitalization
11.05B
6 days until earnings call
Intraday BUY SELL Signals
BAFE
Price
$30.34
Change
-$0.18 (-0.59%)
Updated
Oct 22 closing price
Net Assets
1.77B
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGN vs BAFE

ALGN vs BAFE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALGN vs. BAFE commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a StrongBuy and BAFE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ALGN with price predictions
Oct 22, 2026

ALGN in upward trend: price rose above 50-day moving average on October 22, 2026

ALGN moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 34 of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on ALGN as a result. In 58 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on October 08, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in 32 of 42 cases over the following month. The odds of a continued upward trend are 76%.

Following a +3.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in 192 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

ALGN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ALGN entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. ALGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.610) is normal, around the industry mean (4.961). P/E Ratio (26.951) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.611) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.612) is also within normal values, averaging (56.876).

The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for BAFE with price predictions
Oct 22, 2026

BAFE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for BAFE turned positive on September 22, 2026. Looking at past instances where BAFE's MACD turned positive, the stock continued to rise in 17 of 18 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on BAFE as a result. In 26 of 32 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

BAFE moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BAFE crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +0.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAFE advanced for three days, in 115 of 136 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

The Aroon Indicator entered an Uptrend today. In 99 of 109 cases where BAFE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAFE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

FUNDAMENTALS RATINGS
ALGN: Fundamental Ratings
ALGN
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
69
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGNBAFE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 18 days ago
75%
Bearish Trend 15 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ALGN: $155.51)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 1 FA rating(s) are green while .

  • ALGN’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 4 TA indicator(s) are bullish.

  • ALGN’s TA Score: 4 bullish, 4 bearish.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а +4.13% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 28, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.59% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
ALGN
Daily Signal:
Gain/Loss:
BAFE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been closely correlated with NVST. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALGN jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
+2.74%
NVST - ALGN
71%
Closely correlated
+3.36%
XRAY - ALGN
58%
Loosely correlated
+4.63%
LUNG - ALGN
52%
Loosely correlated
+2.73%
ICUI - ALGN
50%
Loosely correlated
+4.66%
ILMN - ALGN
48%
Loosely correlated
-4.76%
More

BAFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAFE has been loosely correlated with AMZN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if BAFE jumps, then AMZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAFE
1D Price
Change %
BAFE100%
-0.57%
AMZN - BAFE
59%
Loosely correlated
-4.57%
GOOGL - BAFE
56%
Loosely correlated
-3.15%
GOOG - BAFE
56%
Loosely correlated
-3.08%
ALGN - BAFE
54%
Loosely correlated
+2.74%
META - BAFE
51%
Loosely correlated
-6.98%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KMX52.961.47
+2.85%
CarMax
SRTS2.870.01
+0.35%
Sensus Healthcare
STOK25.700.02
+0.08%
Stoke Therapeutics
GOOGL324.22-10.54
-3.15%
Alphabet
IRD3.82-0.29
-7.17%
Opus Genetics Inc